Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $329.5000 (0%) ($326.0000 - $333.3000) on Fri. Mar. 14, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0% (three month average) | RSI | 50 | Latest Price | $329.5000(0%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) FXI(3%) EWG(2%) UUP(2%) EEM(1%) EWI(1%) | Factors Impacting REGN price | REGN will advance at least -0% in a week (0% probabilities). XLV(-3%) XRT(-2%) XLI(-2%) XHB(-2%) PEJ(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | 0% (StdDev 0%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
5 Day Moving Average | $65.9(400%) | 10 Day Moving Average | $0(0%) | 20 Day Moving Average | $0(0%) | To recent high | 0% | To recent low | 0% | Market Cap | $34.936b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |